Gerard Pasterkamp
National University of Singapore
13 Papers
39 Citations
Gerard Pasterkamp is an academic researcher from National University of Singapore. The author has contributed to research in topics: Exosome & Biomarker (medicine). The author has an hindex of 5, co-authored 13 publications.
Chat about Author
Papers
Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring.
Dominique P.V. de Kleijn,Mirjam B. Smeets,Patrick Kemmeren,Sai Kiang Lim,Ben van Middelaar,Evelyn Velema,Arjan H. Schoneveld,Gerard Pasterkamp,Cornelius Borst +8 more
TL;DR: It is concluded that haptoglobin is highly expressed in arterial tissue and is involved in arterials restructuring and may also apply to other functional and pathological restructuring processes such as angiogenesis, tissue repair, and tumor cell invasion.
109
Patent
Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage
Mark Heffernan,Luke A. J. O'Neill,Peter McGuirk,Brian Keogh,Christopher Locher,Dominique De Kleijn,Fatih Arslan,Gerard Pasterkamp +7 more
- 04 Aug 2008
TL;DR: In this paper, the authors provide compounds and methods for the treatment and prophylaxis of ischemia reperfusion injury, in particular, compounds which function to suppress Toll-like Receptor 2 biological function or expression.
10
Images and Case Reports in Interventional Cardiology Subintimal Angioplasty Track of the Superficial Femoral Artery A Histological Analysis
Gert J. de Borst,Frans L. Moll,Gerard Pasterkamp,Aryan Vink +3 more
- 01 Jan 2012
TL;DR: A patient from whom an endarterectomy specimen of an occluded SFA was obtained 2 months after an SIA procedure, which gave the unique opportunity to study the exact route of the subintimal track using histopathology.
7
Patent
Exosomal biomarkers for predicting cardiovascular events
Dominique De Kleijn,Gerard Pasterkamp,Leonardus Timmers,Siu Kwan Sze +3 more
- 17 Feb 2012
TL;DR: In this paper, the authors proposed a method of predicting the risk of a subject developing a cardiovascular event, comprising determining the presence of a biomarker that is indicative of the risk in an exosome sample from the subject.
6
Patent
Composition and method for treatment of reperfusion injury and tissue damage
Mark Heffernan,Luke A. J. O'Neill,Peter McGuirk,Brian Keogh,Christopher Locher,Dominique De Kleijn,Fatih Arslan,Gerard Pasterkamp +7 more
- 04 Aug 2008
TL;DR: In this paper, the authors provide compounds and methods for the treatment and prophylaxis of ischemia reperfusion injury, in particular, compounds which function to suppress Toll-like Receptor 2 biological function or expression.
5